Sorokin, M.; Kholodenko, I.; Kalinovsky, D.; Shamanskaya, T.; Doronin, I.; Konovalov, D.; Mironov, A.; Kuzmin, D.; Nikitin, D.; Deyev, S.;
et al. RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype. Biomedicines 2020, 8, 142.
https://doi.org/10.3390/biomedicines8060142
AMA Style
Sorokin M, Kholodenko I, Kalinovsky D, Shamanskaya T, Doronin I, Konovalov D, Mironov A, Kuzmin D, Nikitin D, Deyev S,
et al. RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype. Biomedicines. 2020; 8(6):142.
https://doi.org/10.3390/biomedicines8060142
Chicago/Turabian Style
Sorokin, Maxim, Irina Kholodenko, Daniel Kalinovsky, Tatyana Shamanskaya, Igor Doronin, Dmitry Konovalov, Aleksei Mironov, Denis Kuzmin, Daniil Nikitin, Sergey Deyev,
and et al. 2020. "RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype" Biomedicines 8, no. 6: 142.
https://doi.org/10.3390/biomedicines8060142
APA Style
Sorokin, M., Kholodenko, I., Kalinovsky, D., Shamanskaya, T., Doronin, I., Konovalov, D., Mironov, A., Kuzmin, D., Nikitin, D., Deyev, S., Buzdin, A., & Kholodenko, R.
(2020). RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype. Biomedicines, 8(6), 142.
https://doi.org/10.3390/biomedicines8060142